Showing all 11 results
Deflazacort Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Steroidal Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the glucocorticoid prodrug.
Active Ingredient Strength Primary Clinical Function Deflazacort USP/Ph.Eur. 6 mg The Pediatric & Titration Standard: The definitive unit utilized for weight-based dosing in pediatric Duchenne Muscular Dystrophy, slow tapering protocols, and chronic low-dose maintenance for rheumatoid arthritis. Deflazacort USP/Ph.Eur. 30 mg The Acute Flare-Up Macrodose: High-efficacy therapeutic payload utilized for the immediate, aggressive suppression of severe allergic anaphylaxis, acute asthma exacerbations, and violent autoimmune flare-ups. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Colloidal Silicon Dioxide Diluent / Binder / Superdisintegrant / Lubricant / Glidant (Engineered utilizing Extreme Multi-Stage Geometric Dilution to ensure the steroidal payload is flawlessly uniform, manufactured under strict OEB 4 containment protocols to prevent cross-contamination and protect facility operators) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict titration, tapering, and chronic immunological dispensing regimens).
Dolutegravir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Polymorphically Stabilized Microdose Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the Dolutegravir Sodium salt.
Active Ingredient Strength Primary Clinical Function Dolutegravir (as Sodium) USP/Ph.Eur. 50 mg The Global INSTI Anchor: The definitive therapeutic payload required to force immediate, systemic viral suppression and maintain an undetectable viral load. Excipients D-Mannitol / Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Sodium Stearyl Fumarate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing strict low-moisture granulation to prevent the active Dolutegravir Sodium from undergoing polymorphic shifts during compression, guaranteeing absolute pharmacokinetic bioequivalence) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for massive NGO distribution and chronic daily dispensing regimens).
Erlotinib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the targeted antineoplastic API.
Active Ingredient Strength Primary Clinical Function Erlotinib (as Hydrochloride) USP/Ph.Eur. 100 mg The Pancreatic Oncology Standard: The definitive daily maintenance dose utilized globally in combination with Gemcitabine for advanced, unresectable, or metastatic pancreatic cancer. Erlotinib (as Hydrochloride) USP/Ph.Eur. 150 mg The Thoracic Oncology Standard: Massive therapeutic payload utilized as a first-line, maintenance, or second-line daily monotherapy for EGFR-mutated Non-Small Cell Lung Cancer. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to maximize dissolution of this highly insoluble compound while locking the potent cytotoxic API safely inside the tablet, completely preventing handler exposure to carcinogenic dust) *Pack Sizes: 3×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Ethinylestradiol & Levonorgestrel Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose FDC Tablet, packed exclusively in highly secure, moisture-resistant “Calendar Blister” packs to ensure absolute daily patient compliance and chemical stability.
Active Ingredient Strength Primary Clinical Function Ethinylestradiol USP/Ph.Eur. 0.03 mg (30 mcg) The Estrogenic Anchor: The synthetic estrogen required to suppress FSH release and stabilize the uterine lining to prevent irregular breakthrough bleeding. Levonorgestrel USP/Ph.Eur. 0.15 mg (150 mcg) The Progestin Powerhouse: The highly potent, second-generation progestin required to suppress the LH surge and thicken the cervical mucus. Excipients Lactose Monohydrate / Maize Starch / Povidone K-30 / Magnesium Stearate / Premium Sugar/Film Coating Diluent / Disintegrant / High-Shear Binder / Lubricant (Engineered specifically using elite multi-stage geometric dilution to guarantee the microscopic 30 mcg and 150 mcg payloads are flawlessly distributed, preventing lethal hormonal drops that cause contraceptive failure) *Pack Sizes: 21-Day Active Blisters OR 28-Day Calendar Blisters (21 Active Hormonal Tablets + 7 Placebo/Iron Tablets to enforce daily habit-forming compliance).
Everolimus Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Antioxidant-Stabilized Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the highly oxidative, potent API.
Active Ingredient Strength Primary Clinical Function Everolimus USP/Ph.Eur. 0.25 mg / 0.5 mg / 0.75 mg Global Transplant Standard: Ultra-micro doses utilized for strict, lifelong immunosuppression following renal or hepatic allografts. Requires extreme content uniformity to maintain the narrow therapeutic blood trough levels (3 to 8 ng/mL). Everolimus USP/Ph.Eur. 5 mg / 10 mg Global Oncology Standard: Massive-dose antineoplastic payload utilized for the aggressive suppression of Renal Cell Carcinoma, Neuroendocrine Tumors (NETs), and HR+/HER2- Breast Cancer. Excipients Butylated Hydroxytoluene (BHT) / Hypromellose / Lactose Anhydrous / Crospovidone / Magnesium Stearate Antioxidant / Binder / Diluent / Superdisintegrant / Lubricant (Engineered specifically utilizing BHT (Butylated Hydroxytoluene) to prevent the rapid oxidative degradation of the Everolimus molecule, guaranteeing maximum clinical shelf-life and potency across harsh climates) *Pack Sizes: 10×10 Alu-Alu Blisters (Transplant) or 3×10 Alu-Alu Blisters (Oncology – 30 Day Supply).
Exemestane Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the potent steroidal antineoplastic agent.
Active Ingredient Strength Primary Clinical Function Exemestane USP/Ph.Eur. 25 mg Global Adult Oncology Standard: The definitive daily maintenance dose required to maintain absolute, continuous destruction of peripheral aromatase enzymes and keep estrogen levels crashed. Excipients Mannitol / Copovidone / Crospovidone / Sodium Starch Glycolate / Magnesium Stearate / Premium Polymeric Film Diluent / High-Shear Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to lock the highly potent, teratogenic steroidal API safely inside the tablet, completely preventing handler and pharmacist exposure to the hazardous dust) *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Flutamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the antiandrogen API.
Active Ingredient Strength Primary Clinical Function Flutamide USP/Ph.Eur. 250 mg Global Uro-Oncology Standard: The definitive therapeutic unit utilized for chronic, 8-hourly maintenance in Maximum Androgen Blockade (MAB) protocols. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to lock the potent antiandrogen API safely inside the tablet, completely preventing handler and pharmacist exposure to the hazardous hormonal dust) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, high-volume chronic oncology dispensing regimens).
Ganciclovir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient and protect healthcare handlers from cytotoxic exposure.
Active Ingredient Strength Primary Clinical Function Ganciclovir USP/Ph.Eur. 250 mg Renal Titration Standard: Base therapeutic unit utilized for strict, calculated dose reductions in transplant patients suffering from severe renal impairment (low creatinine clearance). Ganciclovir USP/Ph.Eur. 500 mg Global Maintenance Standard: High-efficacy adult maintenance dose utilized for daily, long-term suppression of CMV retinitis to prevent viral relapse. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically to lock the highly mutagenic and carcinogenic API safely inside the tablet, completely preventing caregiver and pharmacist exposure to toxic airborne dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 84 (Optimized specifically for strict, high-volume chronic infectious disease dispensing regimens).
Gefitinib tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the targeted antineoplastic agent.
Active Ingredient Strength Primary Clinical Function Gefitinib USP/Ph.Eur. 250 mg Global Adult Oncology Standard: The definitive, highly precise daily maintenance dose required to maintain constant, paralyzing pressure on the mutated EGFR protein to keep the lung cancer in deep molecular remission. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to maximize the dissolution of this poorly soluble compound while locking the cytotoxic API safely inside the tablet, completely preventing handler and pharmacist exposure to the carcinogenic dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Hydroxyurea Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Scored Film-Coated Tablet, packed exclusively in highly secure, handler-protective Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure absolute chemical stability and prevent accidental cytotoxic exposure.
Active Ingredient Strength Primary Clinical Function Hydroxyurea USP/Ph.Eur. 200 mg / 300 mg / 400 mg Pediatric Sickle Cell Standard: Specialized weight-based units designed for exact mg/kg titration in infants and children suffering from severe vaso-occlusive crises. Hydroxyurea USP/Ph.Eur. 500 mg (Scored) Global Adult Hematology Standard: High-efficacy adult maintenance dose for CML, Polycythemia Vera, and adult Sickle Cell Disease. Excipients Microcrystalline Cellulose / Sodium Citrate / Crospovidone / Magnesium Stearate / Premium Polymeric Film Diluent / pH Stabilizer / Superdisintegrant / Slipper-Coating (Engineered specifically with a heavy, durable film-coat to completely seal the highly toxic, mutagenic core away from nurses, parents, and pharmacists) *Pack Sizes: Bottles of 100 or 10×10 Alu-Alu Blisters (Optimized specifically for massive-volume NGO procurement and chronic lifetime dispensing).
Imatinib tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the mesylate salt.
Active Ingredient Strength Primary Clinical Function Imatinib (as Mesylate) USP/Ph.Eur. 100 mg Pediatric & Titration Standard: Base therapeutic unit utilized for weight-based pediatric leukemia dosing, or for highly precise adult dose adjustments during acute hematological toxicity. Imatinib (as Mesylate) USP/Ph.Eur. 400 mg Global Adult Oncology Standard: High-efficacy adult maintenance dose, typically taken once daily for the chronic phase of CML, or twice daily for accelerated phases and GIST. Excipients Microcrystalline Cellulose / Crospovidone / Hypromellose / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Iron-Oxide Film Diluent / Superdisintegrant / Binder / Glidant / Heavy Film-Coating (Engineered specifically to lock the cytotoxic API safely inside the tablet, completely preventing handler and pharmacist exposure to the carcinogenic dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
